News | June 03, 2013

Mevion Delivers Proton Technology to the Stephenson Cancer Center at Oklahoma University

This is the third Mevion S250 proton therapy system delivered

June 3, 2013 — Mevion Medical Systems has delivered the superconducting synchrocyclotron accelerator for its Mevion S250 proton therapy system under installation at the Peggy and Charles Stephenson Cancer Center at the University of Oklahoma.

This is the third single-room Mevion S250 proton therapy system delivered — all installed at leading academic institutions.

”We are delighted to receive this revolutionary machine that will allow us to deliver the same proton treatment as other larger conventional systems but at a fraction of the cost and size and with the most advanced clinical targeting technology” said Mike Samis, chairman of the University Hospitals Authority and Trust. “The addition of this advanced treatment option to our flagship cancer center continues to define the OU Cancer Institute as the state’s leading center of excellence.”

Following a five-day journey from Massachusetts to Oklahoma, the proton accelerator was brought into the Stephenson Cancer Center in only a few hours and will be installed on its gantry. The Mevion S250 is enhancing the center’s state-of-the-art radiation therapy department with a fully integrated proton therapy clinical treatment room. A second Mevion S250 treatment space has been reserved to support future clinical demand.

Powered by a TriNiobium Core, the Mevion S250 is a unique proton therapy system that provides the same precise, non-invasive treatment capabilities and advantages of conventional systems but with significantly reduced size, improved reliability, efficient clinical workflow and lower implementation and operational costs. With a footprint similar to an X-ray radiation therapy device, Mevion proton therapy can be easily integrated into any existing radiation therapy department.

For more information: www.mevion.com

Related Content

New Prostate Cancer Radiotherapy Technique Aims to Preserve Sexual Function
News | Radiation Therapy | June 18, 2018
A multicenter clinical trial being led by UT Southwestern physicians is testing a technique for sparing nerve bundles...
Elekta Unity High-Field MR-Linac Receives CE Mark
News | Image Guided Radiation Therapy (IGRT) | June 18, 2018
Elekta announced that its Elekta Unity magnetic resonance radiation therapy (MR/RT) system has received CE mark,...
Washington University in St. Louis Begins Clinical Treatments With ViewRay MRIdian Linac
News | Image Guided Radiation Therapy (IGRT) | June 14, 2018
June 14, 2018 — The Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in S
Accuray TomoTherapy System Beneficial in Two Total Body Irradiation Studies
News | Radiation Therapy | June 13, 2018
Recently published data from two new studies demonstrate the benefits of Accuray’s TomoTherapy System in the delivery...
IsoRay Funding Brain Cancer Treatment Research With Ochsner Clinic Foundation
News | Brachytherapy Systems | June 12, 2018
IsoRay Inc. announced the initiation of research funding for brain cancer treatment to Ochsner Clinic Foundation, a not...
News | Brachytherapy Systems | June 07, 2018
IsoRay Inc. announced the upcoming release of its Build-Blu delivery system for real-time prostate brachytherapy.
Raysearch RayStation
Feature | Radiation Therapy | June 05, 2018 | By Melinda Taschetta-Millane
Treatment planning systems are at the heart of r...
Beaumont Researchers Invent New Mode of Proton Treatment for Lung Cancer
News | Proton Therapy | May 31, 2018
Members of Beaumont Health’s proton therapy team presented research on a new treatment for patients with lung cancer at...
More Than 60 Percent of Patients Seeking Proton Therapy Initially Denied Coverage
News | Proton Therapy | May 25, 2018
The Alliance for Proton Therapy Access has released a national report revealing the heavy emotional and financial...
News | Treatment Planning | May 24, 2018
Daniela Schmitt, Ph.D., took top honors in the overall category of the 2018 TROG Plan Study: Stereotactic Radiosurgery...
Overlay Init